Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment

Status:
Terminated

Trial end date:
2013-05-01

Target enrollment:

Participant gender:

To compare the activity of AZD8931 against placebo on the cell markers in cancer tumours

Phase 1

AstraZeneca